IMC Chicago’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.06M Buy
145,200
+54,300
+60% +$1.66M ﹤0.01% 1774
2025
Q4
$1.98M Buy
90,900
+49,200
+118% +$1.15M ﹤0.01% 2435
2025
Q3
$950K Sell
41,700
-2,300
-5% -$46.6K ﹤0.01% 2753
2025
Q2
$722K Sell
44,000
-24,300
-36% -$412K ﹤0.01% 2664
2025
Q1
$1.01M Buy
+68,300
New +$1.13M ﹤0.01% 2266
2024
Q1
Sell
-27,000
Closed -$541K 2402
2023
Q4
$541K Buy
27,000
+13,900
+106% +$287K ﹤0.01% 1614
2023
Q3
$246K Buy
+13,100
New +$220K ﹤0.01% 1557
2023
Q1
Sell
-45,300
Closed -$550K 1305
2022
Q4
$550K Buy
+45,300
New +$582K ﹤0.01% 1125

Other funds holding FRO

IMC Chicago's FRO Position: Q1 2026 in Review

IMC Chicago increased its Frontline (FRO) stake by 389% in Q1 2026, buying an estimated $2.79M and bringing the position to 114,698 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

IMC Chicago first reported a position in FRO in Q3 2025 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

  • IMC Chicago held 114,698 shares of Frontline worth $4M as of Q1 2026.
  • IMC Chicago bought 91,230 Frontline shares in Q1 2026, an estimated $2.79M.
  • Frontline made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1981 holding.
  • IMC Chicago first reported a position in Frontline in Q3 2025 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.